In COVID-19 patients, obesity is the factor most associated with
Read moreStudy analyzes association between obesity and endothelial dysfunction in COVID-19 patients
Home »
Semaglutide 2.4 mg ‘Ushers in A New Era in Medical Obesity Care’
The recently licensed weight-loss drug semaglutide 2.4 mg/week (Wegovy, Novo
Read moreHeart disease and obesity driven by liver function – new study
How susceptible we are to obesity and heart disease could
Read moreNew mathematical model could help design new probiotics and tailored diets to prevent diseases
A new mathematical model for the interaction of bacteria in
Read moreHCAs are a promising risk indicator of type 2 diabetes
A series of studies led by researchers from Hong Kong
Read moreHospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
People with obesity who are hospitalized with COVID-19 have a
Read moreObesity raises type 2 diabetes risk in women with PCOS
Women with obesity and polycystic ovarian syndrome (PCOS) are at
Read moreTo Improve PsA Outcomes, Address Common Comorbidities
Only about 30% or fewer of patients with psoriatic arthritis
Read moreObesity a big risk factor for severe COVID-19, study confirms
(HealthDay)—Yet another study confirms what doctors have long known: Being
Read moreObesity may reduce COVID-19 vaccine efficacy, say researchers
A startling new study by researchers at the Istituti Fisioterapici
Read more